79383-45-2

Upstream product

• 917-64-6 methyl magnesium iodide 
• 79383-44-1 methyl 2-methyl-6-methoxybenzoate 
• 6520-83-8 ethyl 2-methoxy-6-methylbenzoate 
• 75-16-1 methylmagnesium bromide 

Downstream Products

• 79383-42-9 2-isopropenyl-3-methylanisole 
• 78347-91-8 4-bromo-2-iso-propyl-3-methylanisole 
• 1642-84-8 2-iso-propyl-3-methylanisole 

Relevant academic research and scientific papers

Novel Phosphinic Acid-Containing Thyromimetics

The present invention relates to compounds of phosphonic acid-containing T3 mimetics and monoesters thereof, stereoisomers, pharmaceutically acceptable salts, co-crystals, and prodrugs thereof and pharmaceutically acceptable salts and co-crystals of the prodrugs, as well as their preparation and uses for preventing and/or treating metabolic diseases such as obesity, NASH, hypercholesterolemia and hyperlipidemia, as well as associated conditions such as atherosclerosis, coronary heart disease, impaired glucose tolerance, metabolic syndrome x and diabetes.

NOVEL PHOSPHORUS-CONTAINING THYROMIMETICS

The present invention relates to compounds of phosphonic acid containing T3 mimetics, stereoisomers, pharmaceutically acceptable salts, co-crystals, and prodrugs thereof and pharmaceutically acceptable salts and co-crystals of the prodrugs, as well as their preparation and uses for preventing and/or treating metabolic diseases such as obesity, NASH, hypercholesterolemia and hyperlipidemia, as well as associated conditions such as atherosclerosis, coronary heart disease, impaired glucose tolerance, metabolic syndromex and diabetes.

REVISION OF THE STRUCTURE ASSIGNED TO A MONOTERPENE ISOLATED FROM PIQUERIA TRINERVIA

Unambiguous synthesis of 2-methyl-3-isopropenylanisole (1) and 2-isopropenyl-3-methylanisole (4) has led to revision, from (1) to (4), of the structure assigned to a monoterpene phenol ether isolated from Piqueria trinervia.